| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Kohei Tanaka, Tomoyuki Furuyashiki, Shiho Kitaoka, Yuta Senzai, Yuki Imoto, Eri Segi-Nishida, Yuichi Deguchi, Richard M Breyer, Matthew D Breyer, Shuh Narumiy. Prostaglandin E2-mediated attenuation of mesocortical dopaminergic pathway is critical for susceptibility to repeated social defeat stress in mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 32. issue 12. 2012-05-18. PMID:22442093. |
given the reported action of ep1 that augments gabaergic inputs to midbrain dopamine neurons, we analyzed dopaminergic response upon social defeat. |
2012-05-18 |
2023-08-12 |
mouse |
| Kohei Tanaka, Tomoyuki Furuyashiki, Shiho Kitaoka, Yuta Senzai, Yuki Imoto, Eri Segi-Nishida, Yuichi Deguchi, Richard M Breyer, Matthew D Breyer, Shuh Narumiy. Prostaglandin E2-mediated attenuation of mesocortical dopaminergic pathway is critical for susceptibility to repeated social defeat stress in mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 32. issue 12. 2012-05-18. PMID:22442093. |
analyses of c-fos expression of vta dopamine neurons and dopamine turnover in mpfc showed that mesocortical dopaminergic pathway is activated upon social defeat and attenuated with repetition of social defeat in wild-type mice. |
2012-05-18 |
2023-08-12 |
mouse |
| Kohei Tanaka, Tomoyuki Furuyashiki, Shiho Kitaoka, Yuta Senzai, Yuki Imoto, Eri Segi-Nishida, Yuichi Deguchi, Richard M Breyer, Matthew D Breyer, Shuh Narumiy. Prostaglandin E2-mediated attenuation of mesocortical dopaminergic pathway is critical for susceptibility to repeated social defeat stress in mice. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 32. issue 12. 2012-05-18. PMID:22442093. |
blockade of dopamine d1-like receptor during social defeat restored social avoidance in ep1-deficient mice, suggesting that disinhibited dopaminergic response during social defeat blocks induction of social avoidance. |
2012-05-18 |
2023-08-12 |
mouse |
| Kristina Fischer, Vesna Sossi, Andreas von Ameln-Mayerhofer, Gerald Reischl, Bernd J Pichle. In vivo quantification of dopamine transporters in mice with unilateral 6-OHDA lesions using [11C]methylphenidate and PET. NeuroImage. vol 59. issue 3. 2012-05-17. PMID:21945469. |
quantification of the binding of [11c]methylphenidate to the dopamine transporter (dat) using positron emission tomography (pet) is often used to evaluate the integrity of dopaminergic neurons in the striatal regions of the brain. |
2012-05-17 |
2023-08-12 |
mouse |
| Monica S Guzman, Xavier De Jaeger, Sanda Raulic, Ivana A Souza, Alex X Li, Susanne Schmid, Ravi S Menon, Raul R Gainetdinov, Marc G Caron, Robert Bartha, Vania F Prado, Marco A M Prad. Elimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission. PLoS biology. vol 9. issue 11. 2012-05-17. PMID:22087075. |
however, dopaminergic sensitivity of medium spiny neurons (msn) and the behavioural outputs in response to direct dopaminergic agonists were enhanced, likely due to increased expression/function of dopamine receptors in the striatum. |
2012-05-17 |
2023-08-12 |
mouse |
| L Lénárd, Z Karád. Regulatory processes of hunger motivated behavior. Acta biologica Hungarica. vol 63 Suppl 1. 2012-05-17. PMID:22453743. |
they are innervated by the mesolimbic dopaminergic system (mlds) and majority of gm neurons are also influenced by dopamine. |
2012-05-17 |
2023-08-12 |
Not clear |
| Jeung Hee An, Tae-Hyung Kim, Byung-Keun Oh, Jeong Woo Cho. Detection of dopamine in dopaminergic cell using nanoparticles-based barcode DNA analysis. Journal of nanoscience and nanotechnology. vol 12. issue 1. 2012-05-15. PMID:22524054. |
detection of dopamine in dopaminergic cell using nanoparticles-based barcode dna analysis. |
2012-05-15 |
2023-08-12 |
Not clear |
| Jeung Hee An, Tae-Hyung Kim, Byung-Keun Oh, Jeong Woo Cho. Detection of dopamine in dopaminergic cell using nanoparticles-based barcode DNA analysis. Journal of nanoscience and nanotechnology. vol 12. issue 1. 2012-05-15. PMID:22524054. |
in this study, we evaluated the efficacy of this bio-barcode dna method in detecting dopamine from dopaminergic cells. |
2012-05-15 |
2023-08-12 |
Not clear |
| Jeung Hee An, Tae-Hyung Kim, Byung-Keun Oh, Jeong Woo Cho. Detection of dopamine in dopaminergic cell using nanoparticles-based barcode DNA analysis. Journal of nanoscience and nanotechnology. vol 12. issue 1. 2012-05-15. PMID:22524054. |
the dopamine concentration in dopaminergic cells can be readily and rapidly detected via the bio-barcode assay method. |
2012-05-15 |
2023-08-12 |
Not clear |
| Zachary Y Weinberg, Marjorie L Nicholson, Paul J Curri. 6-Hydroxydopamine lesions of the ventral tegmental area suppress ghrelin's ability to elicit food-reinforced behavior. Neuroscience letters. vol 499. issue 2. 2012-05-14. PMID:21640160. |
the dopaminergic neurotoxin 6-hydroxydopamine (6-ohda, 6 μg) was subsequently administered into the vta resulting in a significant depletion of striatal dopamine. |
2012-05-14 |
2023-08-12 |
rat |
| Yaochen Li, Chunshi Li, Zhongshan Chen, Jianrong He, Zui Tao, Zheng Qin Yi. A microRNA, mir133b, suppresses melanopsin expression mediated by failure dopaminergic amacrine cells in RCS rats. Cellular signalling. vol 24. issue 3. 2012-05-10. PMID:22101014. |
furthermore, deficient dopaminergic amacrine cells presented decreased th expression and dopamine production, which lead to a failure to direct mrgcs dendrite to stratify and enter inl and lead to the reduced correct connections between amacrine cells and mrgcs. |
2012-05-10 |
2023-08-12 |
rat |
| Yaochen Li, Chunshi Li, Zhongshan Chen, Jianrong He, Zui Tao, Zheng Qin Yi. A microRNA, mir133b, suppresses melanopsin expression mediated by failure dopaminergic amacrine cells in RCS rats. Cellular signalling. vol 24. issue 3. 2012-05-10. PMID:22101014. |
our study suggested that overexpression of mir133b and downregulated pitx3 suppress maturation and function of dopaminergic amacrine cells, and overexpression of mir133b decreased th and d2 receptor expression as well as dopamine production, which finally resulted in reduced melanopsin expression. |
2012-05-10 |
2023-08-12 |
rat |
| Santiago Perez-Lloret, Olivier Rasco. Safety of rasagiline for the treatment of Parkinson's disease. Expert opinion on drug safety. vol 10. issue 4. 2012-05-07. PMID:21453201. |
other dopaminergic agents, such as dopamine agonists, catechol-o-methyl transferase inhibitors and monoamine oxidase b enzyme inhibitors (mao-b i) have also been developed to treat patients with pd. |
2012-05-07 |
2023-08-12 |
Not clear |
| Jeff A Beeler, Cristianne R M Frazier, Xiaoxi Zhuan. Dopaminergic enhancement of local food-seeking is under global homeostatic control. The European journal of neuroscience. vol 35. issue 1. 2012-05-07. PMID:22118191. |
recent work has implicated dopaminergic mechanisms in overeating and obesity with some researchers suggesting parallels between the dopamine dysregulation associated with addiction and an analogous dysregulation in obesity. |
2012-05-07 |
2023-08-12 |
mouse |
| Nandkishor R Kotagale, Brijesh G Taksande, Paresh J Wadhwani, Mahesh W Palhade, Sachin M Mendhi, Dinesh Y Gawande, Pravin N Hadole, Chandrabhan T Chopd. Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodents. Pharmacology, biochemistry, and behavior. vol 100. issue 3. 2012-05-04. PMID:21989253. |
these results indicate that agmatine via regulation of brain dopaminergic signaling modulates dopamine mediated behaviors. |
2012-05-04 |
2023-08-12 |
mouse |
| Rüdiger Hilker, Angelo Antonini, Per Odi. What is the best treatment for fluctuating Parkinson's disease: continuous drug delivery or deep brain stimulation of the subthalamic nucleus? Journal of neural transmission (Vienna, Austria : 1996). vol 118. issue 6. 2012-05-01. PMID:21188435. |
continuous dopaminergic drug delivery (cdd) is based on the steady stimulation of striatal dopamine receptors by subcutaneous apomorphine or duodenal l: -dopa infusions via portable minipumps. |
2012-05-01 |
2023-08-12 |
Not clear |
| Mohammad-Reza Noori-Daloii, Majid Mojarrad, Ali Rashidi-Nezhad, Majid Kheirollahi, Ali Shahbazi, Mehdi Khaksari, Asghar Korzebor, Ali Goodarzi, Maryam Ebrahimi, Ali Reza Noori-Daloi. Use of siRNA in knocking down of dopamine receptors, a possible therapeutic option in neuropsychiatric disorders. Molecular biology reports. vol 39. issue 2. 2012-05-01. PMID:21633887. |
use of dopaminergic antagonists was limited by some serious side effects related to unspecific blocking of dopamine receptors. |
2012-05-01 |
2023-08-12 |
rat |
| Ahrom Ham, Sung-Jin Lee, Jongheon Shin, Kyung-Ho Kim, Woongchon Ma. Regulatory effects of costunolide on dopamine metabolism-associated genes inhibit dopamine-induced apoptosis in human dopaminergic SH-SY5Y cells. Neuroscience letters. vol 507. issue 2. 2012-04-26. PMID:22040670. |
regulatory effects of costunolide on dopamine metabolism-associated genes inhibit dopamine-induced apoptosis in human dopaminergic sh-sy5y cells. |
2012-04-26 |
2023-08-12 |
human |
| Ahrom Ham, Sung-Jin Lee, Jongheon Shin, Kyung-Ho Kim, Woongchon Ma. Regulatory effects of costunolide on dopamine metabolism-associated genes inhibit dopamine-induced apoptosis in human dopaminergic SH-SY5Y cells. Neuroscience letters. vol 507. issue 2. 2012-04-26. PMID:22040670. |
parkinson's disease (pd) is characterized by the selective loss of dopaminergic (daergic) neurons in the substantia nigra and the subsequent depletion of dopamine (da). |
2012-04-26 |
2023-08-12 |
human |
| Anil Kachroo, Michael A Schwarzschil. Adenosine A2A receptor gene disruption protects in an α-synuclein model of Parkinson's disease. Annals of neurology. vol 71. issue 2. 2012-04-26. PMID:22367999. |
the a(2a) ko completely prevented loss of dopamine and dopaminergic neurons caused by the mutant α-synuclein transgene without altering levels of its expression. |
2012-04-26 |
2023-08-12 |
mouse |